This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Medimmune Limited. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Saba Ghazvini: Innovator in Dry Powder Formulations
Introduction
Saba Ghazvini is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biomedical technology, particularly in the development of dry powder formulations for therapeutic applications.
Latest Patents
Ghazvini holds 2 patents related to dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies. His latest patents focus on methods of treating asthma using these formulations, which are designed for pulmonary delivery. The technology aims to improve the efficacy of asthma treatments by utilizing specific antibodies that target TSLP.
Career Highlights
Saba Ghazvini has established himself as a key figure in his field through his innovative work at Medimmune Limited. His research and development efforts have contributed to advancements in asthma treatment methodologies, showcasing his commitment to improving patient outcomes.
Collaborations
Ghazvini has collaborated with several professionals in his field, including Catherine Eugenie Chaillan Huntington and Susan Hoe. These collaborations have likely enhanced the scope and impact of his research.
Conclusion
Saba Ghazvini's work in developing dry powder formulations for asthma treatment represents a significant advancement in biomedical technology. His contributions continue to influence the field and improve therapeutic options for patients.